CAS 1855006-12-0

Formula: C20H18FN5O3

InChI: InChI=1S/C20H18FN5O3/c1-22-19(27)17-9-12(5-7-24-17)26-16-4-3-13(10-15(16)21)29-14-6-8-25-18(11-14)20(28)23-2/h3-11H,1-2H3,(H,22,27)(H,23,28)(H,24,26)

InChI key: USLJNRHZMUHXEP-UHFFFAOYSA-N

SMILES: CNC(=O)C1=NC=CC(=C1)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F

Regorafenib Dipyrimidine

CAS: 1855006-12-0

Purity: 98%

Ref: IN-DA01WZKV

Regorafenib EP Impurity C

CAS: 1855006-12-0

Formula: C₂₀H₁₈FN₅O₃

Color and Shape: Pale Yellow Solid

Molecular weight: 395.39

Ref: 4Z-R-078014

Regorafenib Dipyrimidine

Controlled Product

CAS: 1855006-12-0

Formula: C₂₀H₁₈FN₅O₃

Color and Shape: Neat

Molecular weight: 395.387

Ref: TR-R143355

4-(3-Fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-N-methylpicolinamide

Controlled Product

CAS: 1855006-12-0

Formula: C₂₀H₁₈FN₅O₃

Color and Shape: Neat

Molecular weight: 395.39

Ref: TR-F593180

Regorafenib dipyrimidine

CAS: 1855006-12-0

Regorafenib dipyrimidine is a small molecule with a unique chemical structure that inhibits the activity of multiple receptors and ion channels, such as the epidermal growth factor receptor (EGFR) and potassium channels. The antibody is used to study protein interactions, cell biology, pharmacology, and research tools. It is also used as a reagent for binding peptides and ligands for activation studies. Regorafenib dipyrimidine has been shown to have an inhibitory effect on EGFR-mediated signal transduction pathways in vitro and in vivo. The compound also inhibits proliferation of tumor cells in vitro and reduces tumor burden in vivo.

Formula: C₂₀H₁₈FN₅O₃

Purity: Min. 95%

Molecular weight: 395.4 g/mol

Ref: 3D-FZC00612

Regorafenib EP Impurity C

CAS: 1855006-12-0

Formula: C₂₀H₁₈FN₅O₃

Molecular weight: 395.39

Ref: ST-EA-CP-R59003